Usefullness of arrayCGH for prognostic stratification of chronic lymfocytic leukemia. 28/01/2011 Lees meer
JAK2, as well as PDL1 and PDL2, are recurrently targeted by 9p24 structural and numerical aberrations in lymphoid neoplasms of both B- and T-cell origin 01/01/2011 Lees meer
JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma. 01/01/2011 Lees meer
